Bora Pharmaceuticals Co., LTD. (TPE:6472)
512.00
-10.00 (-1.92%)
At close: Jan 21, 2026
TPE:6472 Market Cap
TPE:6472 has a market cap or net worth of 63.5 billion as of January 21, 2026. Its market cap has decreased by -16.85% in one year.
Market Cap
63.50B
Enterprise Value
80.64B
Revenue
21.10B
Ranking
n/a
PE Ratio
15.71
Stock Price
512.00
Market Cap Chart
Since October 3, 2014, TPE:6472's market cap has increased from 3.16B to 63.50B, an increase of 1,908.32%. That is a compound annual growth rate of 30.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 63.50B | 4.92% |
| Dec 31, 2025 | 60.52B | -22.12% |
| Dec 31, 2024 | 77.71B | 20.27% |
| Dec 29, 2023 | 64.61B | 107.61% |
| Dec 30, 2022 | 31.12B | 150.04% |
| Dec 30, 2021 | 12.45B | 17.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 215.25B |
| Lotus Pharmaceutical | 82.58B |
| Center Laboratories | 31.13B |
| ScinoPharm Taiwan | 22.34B |
| TTY Biopharm Company | 20.86B |
| Alar Pharmaceuticals | 18.17B |
| Grape King Bio | 18.00B |
| Synmosa Biopharma | 16.40B |